Diagnosis and Management of Pregnancy-Related Pruritus

Introduction to Pregnancy-Specific Dermatoses

• The American College of Obstetricians and Gynecologists states that intrahepatic cholestasis of pregnancy (ICP) diagnosis is based on pruritus symptoms supported by elevated total serum bile acid levels 1
• ICP requires elevated bile acids for diagnosis, and bile acids are the most sensitive and specific marker for this condition 1, 2, 3
• Normal bile acids effectively exclude ICP as the primary diagnosis at this time, but do not rule out the possibility of ICP developing later in pregnancy 2, 3

Diagnostic Considerations

• The American College of Obstetricians and Gynecologists recommends a detailed skin examination to identify any rash, excoriations, papules, plaques, or vesicles that would distinguish dermatologic conditions from ICP 1
• Assess for excoriations from scratching versus primary skin lesions, as this can help differentiate between ICP and other dermatologic conditions 1, 3
• Obtain a detailed history, including personal or family history of atopy, recent medication changes, and other potential causes of pruritus 1, 3

Pregnancy-Specific Dermatoses

• Atopic eruption of pregnancy is the most common dermatosis of pregnancy, affecting approximately 23% of pregnancies, and often presents with pruritus and a visible eczematous rash 1, 2
• Polymorphic eruption of pregnancy is the second most common pregnancy-specific dermatosis, characterized by pruritic urticarial papules and plaques on the abdomen and proximal thighs 1
• Both conditions typically present with visible skin changes, which can help differentiate them from ICP 1

Management Approach

• If skin examination reveals a rash, diagnose based on rash morphology and distribution, and treat symptomatically with topical corticosteroids and antihistamines 1
• If no rash is present, repeat bile acid testing in 1-2 weeks if symptoms persist or worsen, as ICP cannot be definitively excluded with a single normal result when clinical suspicion is high 2, 3
• Consider empiric symptomatic treatment with antihistamines while awaiting repeat testing, but do not initiate ursodeoxycholic acid without confirmed elevated bile acids 2, 3

Critical Pitfalls to Avoid

• Never assume ICP is excluded permanently based on one normal bile acid level if pruritus persists, especially given the patient is only at 21 weeks gestation 3
• Serial monitoring is warranted if symptoms continue despite normal initial testing, as ICP can develop later in pregnancy 3
• Repeat bile acids urgently if the patient develops worsening pruritus, dark urine, jaundice, or elevated liver transaminases, as these findings increase suspicion for ICP despite initially normal bile acids 1, 2, 3